Peter N Reikes - Net Worth and Insider Trading

Peter N Reikes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter N Reikes owns 1 companies in total, including Ionis Pharmaceuticals Inc (IONS) .

Click here to see the complete history of Peter N Reikes’s form 4 insider trades.

Insider Ownership Summary of Peter N Reikes

Ticker	Comapny	Transaction Date	Type of Owner
IONS	Ionis Pharmaceuticals Inc	2018-09-23	director

Peter N Reikes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter N Reikes Ownership Network

Ownership Network List of Peter N Reikes

No Data

Ownership Network Relation of Peter N Reikes

Peter N Reikes Owned Company Details

What does Ionis Pharmaceuticals Inc do?

Who are the key executives at Ionis Pharmaceuticals Inc?

Peter N Reikes is the director of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include SVP & Research Eric Swayze , Senior Vice President Richard S Geary , and EVP & Corp and Development Ops Brian Birchler .

Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary

Over the past 18 months, Peter N Reikes made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 181,397 shares made by Brett P Monia , a net sale of 35,600 shares made by Richard S Geary , and a net sale of 60,168 shares made by C Frank Bennett .

In summary, during the past 3 months, insiders sold 704 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 704 shares. During the past 18 months, 614,196 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 614,196 shares.

Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ionis Pharmaceuticals Inc Insider Transactions

No Available Data

Peter N Reikes Mailing Address

Above is the net worth, insider trading, and ownership report for Peter N Reikes. You might contact Peter N Reikes via mailing address: C/o Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad Ca 92010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.